B

BioAge Labs Inc.
D

BIOA

20.290
USD
-0.06
(-0.29%)
مغلق
حجم التداول
34,662
الربح لكل سهم
-2
العائد الربحي
-
P/E
1
حجم السوق
847,157,657
أصول ذات صلة المقالات

العنوان: BioAge Labs Inc.

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.